Robin L. Smith, Executive Chair of the Board, Director at Lisata Therapeutics, holds 236.07K shares in Celularity (Ticker: CELU), holds 235.00K shares in Sorrento Therapeutics (Ticker: SRNEQ), holds 167.97K shares in ServiceSource International (Ticker: SREV).
What is the percentage of profitable transactions made by Robin L. Smith?
The percentage of profitable transactions made by Robin L. Smith is 43%.
What is the average return per transaction made by Robin L. Smith?
The average return per transaction made by Robin L. Smith is 14.80%.
What stocks does Robin L. Smith hold?
Robin L. Smith holds: LSTA, RMTI, EMMA, SEEL, SRNEQ, SREV, CELU, VRDN stocks.
What was Robin L. Smith’s latest transaction?
Robin L. Smith latest transaction was an Uninformative Buy of ―.
What was Robin L. Smith's most profitable transaction?
Robin L. Smith’s most profitable transaction was an Informative Buy of SRNEQ stock on March 5, 2020. The return on the trade was 282.70%.
What is Robin L. Smith's role in Lisata Therapeutics?
Robin L. Smith's role in Lisata Therapeutics is Executive Chair of the Board, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.